Confluent, Inc.

NASDAQ:CFLT

26.13 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 261.22250.199234.986217.237213.184200.181189.285174.302168.666151.732139.407126.139119.928102.5788.33877.02870.32461.49753.85250.904
Cost of Revenue 67.56563.70364.9461.22157.05756.54957.9258.14453.94953.1849.50945.77746.14637.29930.00923.83820.91719.05617.6917.813
Gross Profit 193.655186.496170.046156.016156.127143.632131.365116.158114.71798.55289.89880.36273.78265.27158.32953.1949.40742.44136.16233.091
Gross Profit Ratio 0.7410.7450.7240.7180.7320.7180.6940.6660.680.650.6450.6370.6150.6360.660.6910.7030.690.6720.65
Reseach & Development Expenses 114.886102.72106.02797.57186.94891.23785.67784.8971.80970.09964.47257.66156.68647.70133.22524.31321.86144.92118.87519.742
General & Administrative Expenses 39.35939.47139.42938.44433.94831.87436.34335.35535.20933.04129.97927.48130.15125.3337.94315.51212.00993.7588.3348.415
Selling & Marketing Expenses 145.194137.968132.865131.352119.911128.624127.77128.624122.684114.312112.754106.702100.62586.99173.20658.50947.83843.75936.44738.317
SG&A 184.553177.439172.199169.796153.859160.498164.113163.979157.893147.353142.733134.183130.776112.321111.14974.02159.847137.51744.78146.732
Other Expenses 0021.85320.8521.77517.52917.6115.18511.3271.572-1.432-1.382-0.518-0.53-0.643-0.336-0.302-0.153-0.211-0.307
Operating Expenses 299.439280.159278.226267.367240.807251.735249.79248.869229.702217.452207.205191.844187.462160.022144.37498.33481.708182.43863.65666.474
Operating Income -105.784-93.663-108.18-111.351-84.68-108.632-119.368-132.711-114.985-118.9-117.307-111.482-113.68-94.751-86.045-45.144-32.301-139.997-27.494-33.383
Operating Income Ratio -0.405-0.374-0.46-0.513-0.397-0.543-0.631-0.761-0.682-0.784-0.841-0.884-0.948-0.924-0.974-0.586-0.459-2.276-0.511-0.656
Total Other Income Expenses Net 19.28822.49521.85320.8521.77517.52917.61-18.19711.3274.7191.186-0.816-0.329-0.2310.0450.5080.8061.1061.0920.136
Income Before Tax -86.496-71.168-86.496-90.501-62.905-91.103-101.758-150.908-103.658-114.181-116.121-112.298-114.009-94.982-86-44.636-31.495-138.891-26.402-33.247
Income Before Tax Ratio -0.331-0.284-0.368-0.417-0.295-0.455-0.538-0.866-0.615-0.753-0.833-0.89-0.951-0.926-0.974-0.579-0.448-2.259-0.49-0.653
Income Tax Expense 1.5582.9763.4042.46631.1911.5671.6671.6472.2261.8681.510.6890.430.6842.17-0.110.261-0.75-0.1060.388
Net Income -88.054-74.144-89.9-92.967-94.096-92.67-103.425-152.555-105.884-116.049-117.631-112.987-114.439-95.666-88.17-44.526-31.756-138.141-26.296-33.635
Net Income Ratio -0.337-0.296-0.383-0.428-0.441-0.463-0.546-0.875-0.628-0.765-0.844-0.896-0.954-0.933-0.998-0.578-0.452-2.246-0.488-0.661
EPS -0.27-0.23-0.28-0.3-0.3-0.3-0.35-0.52-0.37-0.41-0.42-0.41-0.43-0.37-0.74-0.18-0.14-0.62-0.12-0.15
EPS Diluted -0.27-0.23-0.28-0.3-0.3-0.3-0.35-0.52-0.37-0.41-0.42-0.41-0.43-0.37-0.74-0.18-0.14-0.62-0.12-0.15
EBITDA -105.784-87.961-102.507-107.04-80.757-104.494-115.169-129.589-112.5-116.825-115.497-110.232-112.488-93.854-85.289-44.357-31.921-139.509-27.06-33.118
EBITDA Ratio -0.405-0.352-0.436-0.493-0.397-0.519-0.603-0.552-0.667-0.77-0.828-0.874-0.938-0.915-0.965-0.576-0.454-2.269-0.502-0.651